STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

AMETEK CEO reports 88,000-share option exercise and stock sales

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

AMETEK, Inc. (AME) reported an insider transaction by its Chief Executive Officer and director. On 11/25/2025, the reporting person exercised 88,000 stock options at an exercise price of $63.37 per share, acquiring the same number of AMETEK common shares.

On the same date, the insider sold an aggregate of 88,000 common shares in three transactions: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with detailed price ranges provided in the notes. After these transactions, the insider directly owned 348,955 shares of common stock, plus 23,982 common stock/ SERP units and 11,080 stock options.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ZAPICO DAVID A

(Last) (First) (Middle)
1100 CASSATT ROAD

(Street)
BERWYN PA 19312-1177

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF EXECUTIVE OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/25/2025 M 88,000 A $63.37 436,955 D
Common Stock 11/25/2025 S 7,432 D $194.89(1) 429,523 D
Common Stock 11/25/2025 S 25,815 D $195.82(2) 403,708 D
Common Stock 11/25/2025 S 54,753 D $196.86(3) 348,955 D
Common Stock/ Serp 23,982 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $63.37 11/25/2025 M 88,000 (4) 03/20/2030 Common Stock 88,000 $0 11,080 D
Explanation of Responses:
1. The shares were sold at prices ranging from $194.52 to 195.28. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price.
2. The shares were sold at prices ranging from $195.29 to $196.27. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price.
3. The shares were sold at prices ranging from $196.28 to $197.27. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price.
4. The stock options became exercisable in three equal annual installments beginning on March 20, 2021.
Remarks:
/s/ Lynn Carino, attorney-in-fact for Mr. Zapico 11/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AMETEK (AME) report on this Form 4?

The filing reports that AMETEK’s Chief Executive Officer, who is also a director, exercised 88,000 stock options and sold a total of 88,000 common shares of AMETEK, Inc. common stock on 11/25/2025.

What was the exercise price of the AMETEK (AME) stock options?

The reported stock options were exercised at a price of $63.37 per share, covering 88,000 underlying shares of AMETEK common stock.

At what prices were AMETEK (AME) shares sold by the insider?

The insider reported three sales on 11/25/2025: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with price ranges detailed in the footnotes.

How many AMETEK (AME) shares does the insider own after the reported transactions?

Following the reported transactions, the insider directly owned 348,955 shares of AMETEK common stock and 23,982 additional common stock/ SERP units, along with 11,080 stock options.

What are the details of the AMETEK (AME) stock options exercised?

The exercised stock options related to 88,000 underlying shares of AMETEK common stock, had an exercise price of $63.37, and carried an expiration date of 03/20/2030. They became exercisable in three equal annual installments beginning on March 20, 2021.

Is the AMETEK (AME) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, who is both a director and the Chief Executive Officer of AMETEK, Inc.
Ametek

NYSE:AME

AME Rankings

AME Latest News

AME Latest SEC Filings

AME Stock Data

45.18B
229.27M
0.36%
90.08%
1.13%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States
BERWYN